Claire Drolen

Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death

Trinayan Kashyap, Christian Argueta, Amro Aboukameel et al. · Oncotarget · 2016 · 132 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium

Talal El Zarif, Amin H. Nassar, Elio Adib et al. · Journal of Clinical Oncology · 2023 · 69 citations · Full text

Life Sciences, Immunology, Oncology +17

pH-Driven Mechanistic Switching from Electron Transfer to Energy Transfer between [Ru(bpy)₃]²⁺ and Ferrocene Derivatives

Claire Drolen, Eric Conklin, Stephen J. Hetterich et al. · Journal of the American Chemical Society · 2018 · 25 citations

Natural Sciences, Chemistry, Electrochemistry +15

Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States

Kathryn Lurain, Talal El Zarif, Ramya Ramaswami et al. · Clinical Lymphoma Myeloma & Leukemia · 2024 · 14 citations · Full text

Life Sciences, Immunology, Oncology +15

Surrogate Perspectives on Patient Preference Predictors: Good Idea, but I Should Decide How They Are Used

Dana Howard, Allan Rivlin, Philip J. Candilis et al. · AJOB Empirical Bioethics · 2022 · 13 citations · Full text

Business, Health Services Administration, Decision Analysis +15